MNPR

NASDAQStock

Monopar Therapeutics Inc.

$59.82+2.13 (+3.70%)

52-Week Range

$28.89
$102.05

Key Stats

Market Cap

399.8M

P/E Ratio

Dividend Yield

Beta

1.67

Volume

304.3K

Avg Volume

152.0K

Performance

1M

-2.77%

3M

-23.32%

6M

+5.71%

YTD

-12.74%

1Y

+93.61%

3Y

+338.02%

5Y

+41.35%

Price Chart

ETF Exposure

MNPR is held by 42 ETFs

ETFFund NameWeight
BBCVirtus Biotech Clinical Trials ETF0.60%
VFMOVanguard U.S. Momentum Factor ETF0.09%
IWCiShares Micro-Cap ETF0.05%
VMO.TOVanguard Global Momentum Factor ETF0.05%
GSSCGoldman Sachs ActiveBeta U.S. Small Cap Equity ETF0.03%
IWOiShares Russell 2000 Growth ETF0.02%
VTWGVanguard Russell 2000 Growth ETF0.02%
OMFSInvesco Russell 2000 Dynamic Multifactor ETF0.01%
RESMColumbia Research Enhanced Small Cap ETF0.01%
IWMiShares Russell 2000 ETF0.01%
VTWOVanguard Russell 2000 ETF0.01%
XRS2.DEXtrackers Russell 2000 UCITS ETF 1C0.01%
XRSU.LXtrackers Russell 2000 UCITS ETF 1C0.01%
XSU.TOiShares U.S. Small Cap Index ETF (CAD-Hedged)0.01%
SC0K.DEInvesco Russell 2000 UCITS ETF0.01%
R2SC.LState Street SPDR Russell 2000 U.S. Small Cap UCITS ETF (Acc)0.01%
RSSLGlobal X - Russell 2000 ETF0.01%
UWMProShares - Ultra Russell20000.01%
URTYProShares - UltraPro Russell20000.01%
VXFVanguard Extended Market ETF0.00%
AVSCAvantis U.S. Small Cap Equity ETF0.00%
ITOTiShares Core S&P Total U.S. Stock Market ETF0.00%
SMMDiShares Russell 2500 ETF0.00%
HDGProShares - Hedge Replication ETF0.00%
XEQT.TOiShares Core Equity ETF Portfolio0.00%
XUU.TOiShares Core S&P U.S. Total Market Index ETF0.00%
ITDBiShares LifePath Target Date 2030 ETF0.00%
ITDCiShares LifePath Target Date 2035 ETF0.00%
ITDDiShares LifePath Target Date 2040 ETF0.00%
ITDEiShares LifePath Target Date 2045 ETF0.00%
ITDFiShares LifePath Target Date 2050 ETF0.00%
ITDGiShares LifePath Target Date 2055 ETF0.00%
ITDHiShares LifePath Target Date 2060 ETF0.00%
ITDIiShares LifePath Target Date 2065 ETF0.00%
ITDJiShares LifePath Target Date 2070 ETF0.00%
VCNS.TOVanguard Conservative ETF Portfolio0.00%
VEQT.TOVanguard All-Equity ETF Portfolio0.00%
VRIF.TOVanguard Retirement Income ETF Portfolio0.00%
VTHRVanguard Russell 3000 ETF0.00%
VTIVanguard Total Stock Market ETF0.00%
VUN.TOVanguard U.S. Total Market Index ETF0.00%
VUS.TOVanguard U.S. Total Market Index ETF (CAD-hedged)0.00%

About MNPR ETF Exposure

Monopar Therapeutics Inc. (MNPR) is held by 42 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 399.8M, MNPR is a widely held institutional stock. The stock currently trades at $59.82. Investors can gain exposure to MNPR through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold MNPR, sorted by portfolio weight.